FCER2 Antikörper (Biotin)
-
- Target Alle FCER2 Antikörper anzeigen
- FCER2 (Fc Fragment of IgE, Low Affinity II, Receptor For (CD23) (FCER2))
-
Reaktivität
- Human
-
Wirt
- Maus
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser FCER2 Antikörper ist konjugiert mit Biotin
-
Applikation
- Flow Cytometry (FACS), Western Blotting (WB), Immunohistochemistry (IHC), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
- Spezifität
- CD23 Molecule of 45 kd.
- Aufreinigung
- Protein A purified
- Immunogen
-
Human peripheral myeloma cells.
Type of Immunogen: Cells - Klon
- Bu38
- Isotyp
- IgG1
- Top Product
- Discover our top product FCER2 Primärantikörper
-
-
- Applikationshinweise
-
Approved: Flo, IHC, IHC-P, WB
Usage: The applications listed have been tested for the unconjugated form of this product. Other forms have not been tested. - Kommentare
-
Target Species of Antibody: Human
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- Lot specific
- Buffer
- 50 mM sodium phosphate, pH 7.5, 100 mM potassium chloride, 150 mM sodium chloride, 5 % Glycerol, 0.2 % BSA, 0.04 % sodium azide
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Handhabung
- Do not freeze.
- Lagerung
- 4 °C
- Informationen zur Lagerung
- Store at 4°C. Do not freeze.
-
- Target
- FCER2 (Fc Fragment of IgE, Low Affinity II, Receptor For (CD23) (FCER2))
- Andere Bezeichnung
- FCER2 / CD23 (FCER2 Produkte)
- Synonyme
- BLAST-2 antikoerper, CD23 antikoerper, CD23A antikoerper, CLEC4J antikoerper, FCE2 antikoerper, IGEBF antikoerper, Fcer2a antikoerper, Fc fragment of IgE receptor II antikoerper, FCER2 antikoerper, Fcer2 antikoerper
- Hintergrund
-
Name/Gene ID: FCER2
Synonyms: FCER2, CD23 antigen, CD23A, CLEC4J, CD23, Fc-epsilon-RII, IGEBF, Lymphocyte IgE receptor, BLAST-2, FCE2 - Gen-ID
- 2208
- UniProt
- P06734
- Pathways
- Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process
-